Jump to content

Talk:Axitinib

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

trial on previously untreated RCC

[edit]

ASCO: VEGF Blocker Active in Metastatic RCC is only phase II but suggests it may also be effective in previously untreated RCC. - Rod57 (talk) 14:57, 10 June 2012 (UTC)[reply]

Encouraging results in RCC from a trial in combination with a PD1-inhibitor pembrolizumab

[edit]

Says 'Unprecedented' 73% Response Rate With Combo in Untreated RCC - suggests due to it being a more selective VEGF inhibitor. These results gained FDA Breakthrough designation for the combination. - Rod57 (talk) 18:03, 19 February 2018 (UTC)[reply]